GPR183 and metabolic disease: Despite the altered levels of oxysterols in metabolic diseases and our current insight into the role of GPR183 in the intestinal immune response, combined with a recently proven expression of GPR183 in rat and human islets [25], surprisingly little is known about GPR183 in metabolic diseases.